rs3136056

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_005236.3(ERCC4):​c.252C>T​(p.Leu84Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00789 in 1,613,702 control chromosomes in the GnomAD database, including 140 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0090 ( 21 hom., cov: 32)
Exomes 𝑓: 0.0078 ( 119 hom. )

Consequence

ERCC4
NM_005236.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.339

Publications

6 publications found
Variant links:
Genes affected
ERCC4 (HGNC:3436): (ERCC excision repair 4, endonuclease catalytic subunit) The protein encoded by this gene forms a complex with ERCC1 and is involved in the 5' incision made during nucleotide excision repair. This complex is a structure specific DNA repair endonuclease that interacts with EME1. Defects in this gene are a cause of xeroderma pigmentosum complementation group F (XP-F), or xeroderma pigmentosum VI (XP6).[provided by RefSeq, Mar 2009]
ERCC4 Gene-Disease associations (from GenCC):
  • xeroderma pigmentosum group F
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, ClinGen
  • Fanconi anemia complementation group Q
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • XFE progeroid syndrome
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum-Cockayne syndrome complex
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 16-13922075-C-T is Benign according to our data. Variant chr16-13922075-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 240124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.339 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00902 (1373/152184) while in subpopulation NFE AF = 0.00781 (531/68014). AF 95% confidence interval is 0.00726. There are 21 homozygotes in GnomAd4. There are 820 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC4NM_005236.3 linkc.252C>T p.Leu84Leu synonymous_variant Exon 2 of 11 ENST00000311895.8 NP_005227.1 Q92889-1A0A1W1GSK9
ERCC4XM_011522424.4 linkc.252C>T p.Leu84Leu synonymous_variant Exon 2 of 12 XP_011520726.1 A0A804HKF9
LOC105371093XR_007064999.1 linkn.82+4450G>A intron_variant Intron 1 of 2
LOC105371093XR_007065000.1 linkn.82+4450G>A intron_variant Intron 1 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC4ENST00000311895.8 linkc.252C>T p.Leu84Leu synonymous_variant Exon 2 of 11 1 NM_005236.3 ENSP00000310520.7 Q92889-1

Frequencies

GnomAD3 genomes
AF:
0.00903
AC:
1373
AN:
152066
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00114
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00950
Gnomad EAS
AF:
0.000965
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0657
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00781
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.0100
AC:
2522
AN:
251282
AF XY:
0.00975
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.00962
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0646
Gnomad NFE exome
AF:
0.00778
Gnomad OTH exome
AF:
0.00848
GnomAD4 exome
AF:
0.00777
AC:
11356
AN:
1461518
Hom.:
119
Cov.:
31
AF XY:
0.00752
AC XY:
5465
AN XY:
727084
show subpopulations
African (AFR)
AF:
0.000837
AC:
28
AN:
33470
American (AMR)
AF:
0.000939
AC:
42
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
264
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00179
AC:
154
AN:
86236
European-Finnish (FIN)
AF:
0.0578
AC:
3089
AN:
53408
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.00664
AC:
7378
AN:
1111734
Other (OTH)
AF:
0.00656
AC:
396
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
556
1112
1667
2223
2779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00902
AC:
1373
AN:
152184
Hom.:
21
Cov.:
32
AF XY:
0.0110
AC XY:
820
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41504
American (AMR)
AF:
0.00262
AC:
40
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00950
AC:
33
AN:
3472
East Asian (EAS)
AF:
0.000967
AC:
5
AN:
5170
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
0.0657
AC:
695
AN:
10586
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00781
AC:
531
AN:
68014
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
69
138
208
277
346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00714
Hom.:
9
Bravo
AF:
0.00419
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.00551
EpiControl
AF:
0.00581

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
May 07, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ERCC4: BP4, BP7, BS2 -

Mar 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Xeroderma pigmentosum, group F Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
8.2
DANN
Benign
0.80
PhyloP100
0.34
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3136056; hg19: chr16-14015932; COSMIC: COSV104606275; COSMIC: COSV104606275; API